Cargando…
Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases
Renal fibrosis is the inevitable common end-point of all progressive chronic kidney diseases. The underlying mechanisms of renal fibrosis are complex, and currently there is no effective therapy against renal fibrosis. Renal microvascular rarefaction contributes to the progression of renal fibrosis;...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154791/ https://www.ncbi.nlm.nih.gov/pubmed/35618410 http://dx.doi.org/10.1080/0886022X.2022.2079528 |